
|Articles|March 29, 2021
Cytel Opens Solara to General Release & Launches New Trial Optimization Solution for Biotechs
Advertisement
Cytel announces that its clinical trial design and statistical software solution Solara is now available for general release to the pharma industry. Solara is available in two formats: standalone SaaS product, and as part of a consultancy solution. The consultancy solution is directed to smaller biopharma companies, which may lack an in-house biostatistician to lead the clinical trial design process.
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Patient Recruitment in Clinical Trials: Why the Industry's Longstanding Approach Is No Longer Fit for Purpose
2
ACT Brief: Local-First Communication Design, RBQM Financial Impact, and First Oral PCSK9 Inhibitor
3
Applying Systems Thinking to the Future of Clinical R&D
4
ACT Brief: CRO Partnership in Program Recruitment, Psychedelic Trial Design Guidance, and Breast Cancer Pathway Inhibitor
5




